Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
CC transcript
Filed Chapter 11
Director departure
|
|
BAXANO SURGICAL, INC. (BAXS)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 11/14/2014 |
8-K
| Quarterly results |
| 11/12/2014 |
8-K
| Resignation/termination of a director |
| 10/31/2014 |
8-K
| Resignation/termination of a director |
| 09/24/2014 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
| 08/05/2014 |
8-K
| Quarterly results |
| 07/14/2014 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits |
| 06/06/2014 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing |
| 05/08/2014 |
8-K
| Quarterly results |
| 04/17/2014 |
8-K
| Submission of Matters to a Vote of Security Holders |
| 03/14/2014 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...|
Docs:
|
"Form of Securities Purchase Agreement, by and among Baxano Surgical, Inc. and the purchasers named therein",
"Subordination Agreement, by and among Baxano Surgical, Inc., Hercules Technology Growth Capital, Inc., and the creditors named therein",
"General Release and Severance Agreement, between Baxano Surgical, Inc. and Rick Feiler",
"Baxano Surgical, Inc. Announces $10 Million Private Placement of Convertible Debentures",
"Baxano Surgical, Inc. Announces Changes to Executive Management Team RALEIGH, NC — —March 14, 2014— Baxano Surgical, Inc. , a medical device company focused on designing, developing and marketing minimally invasive products to treat degenerative conditions of the spine affecting the lumbar region, today announced changes to its executive management team. · Tim Shannon has been appointed Chief Financial Officer effective March 14, 2014 · Matt Pickens has been appointed Vice President of Marketing and Reimbursement effective March 14, 2014 · Rick Feiler, Vice President of Marketing & Professional Education, has resigned effective April 15, 2014 and will assist in the transition process over the next month Tim Shannon joined Baxano Surgical in 2013 and has served as Inter..." |
|
| 03/07/2014 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits |
| 02/11/2014 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 01/17/2014 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits |
| 01/08/2014 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 12/03/2013 |
8-K
| Form 8-K - Current report |
| 08/12/2013 |
8-K
| Quarterly results |
| 06/26/2013 |
8-K/A
| Financial Statements and Exhibits|
Docs:
|
"Consent of PricewaterhouseCoopers LLP",
"Audited Financial Statements of Baxano, Inc. as of and for the years ended December 31, 2012 and 2011",
"Unaudited Financial Statements of Baxano, Inc. as of March 31, 2013 and December 31, 2012 and for the three months ended March 31, 2013 and 2012",
"Unaudited Pro Forma Condensed Combined Financial Information of Baxano Surgical, Inc" |
|
| 05/10/2013 |
8-K
| Quarterly results |
| 04/22/2013 |
8-K
| Entry into a Material Definitive Agreement |
| 03/05/2013 |
8-K
| Quarterly results|
Docs:
|
"Agreement and Plan of Merger, among TranS1 Inc., RacerX Acquisition Corp., Baxano, Inc., and Sumeet Jain and David Schulte as Securityholder Representatives",
"List of Schedules Omitted from Agreement and Plan of Merger included as Exhibit 2.1 above",
"Form of Securities Purchase Agreement, between TranS1 Inc. and the investors identified on the signature pages thereto",
"TranS1 Inc. Consolidated Statements of Operations and Comprehensive Loss Three Months Ended December 31, Twelve Months Ended December 31, 2012 2011 2012 2011 Revenue $ 4,129 $ 3,990 $ 14,570 $ 19,153 Cost of revenue 1,562 1,042 4,309 4,555 Gross profit 2,567 2,948 10,261 14,598 Operating expenses: Research and development 1,520 1,350 5,457 5,191 Sales and marketing 4,925 4,906 20,049 21,561 General and administrative 1,510 1,368 6,172 5,890 Charges related to U.S. Government settlement 6,583 235 8,324 235 Total operating expenses 14,538 7,859 40,002 32,877 Operating loss Other income , net 6 Net loss $ $ $ $ Other comprehensive loss: Foreign currency translation adjustments - 40 1 42 Comprehensive loss $ $ $ $ Net loss per common share - basic and diluted $ $ $ $ Weighted average commo...",
"Conference call transcript",
"Joseph P. Slattery, 919-825-0868 Executive Vice-President and Chief Financial Officer" |
|
| 02/19/2013 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 11/13/2012 |
8-K
| Quarterly results |
| 10/12/2012 |
8-K
| Form 8-K - Current report |
| 09/21/2012 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits |
| 08/15/2012 |
8-K
| Quarterly results|
Docs:
|
"TranS1 Inc. Consolidated Statements of Operations and Comprehensive Loss Three Months Ended June 30, Six Months Ended June 30, 2012 2011 2012 2011 Revenue $ 3,460 $ 5,337 $ 7,243 $ 10,467 Cost of revenue 912 1,173 1,909 2,469 Gross profit 2,548 4,164 5,334 7,998 Operating expenses: 73.6 % 78.0 % 73.6 % 76.4 % Research and development 1,244 1,212 2,577 2,794 Sales and marketing 5,371 5,671 10,670 12,054 General and administrative 2,224 1,610 4,106 3,223 Total operating expenses 8,839 8,493 17,353 18,071 Operating loss Other income , net 20 38 Net loss $ $ $ $ Other comprehensive income : Foreign currency translation adjustments - 6 - 14 Comprehensive loss $ $ $ $ Net loss per common share - basic and diluted $ $ $ $ Weighted average common shares outstanding - basic and diluted 27,255 20...",
"Conference call transcript" |
|
| 06/08/2012 |
8-K
| Form 8-K - Current report |
| 05/11/2012 |
8-K
| Quarterly results |
| 04/05/2012 |
8-K
| Form 8-K - Current report |
| 03/13/2012 |
8-K
| Form 8-K - Current report |
| 03/05/2012 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits |
| 01/27/2012 |
8-K
| Regulation FD Disclosure |
| 01/19/2012 |
8-K
| Form 8-K - Current report |
| 11/17/2011 |
8-K
| Form 8-K - Current report |
| 11/09/2011 |
8-K
| Form 8-K - Current report |
|
|
|